Impact of cross-sex hormone therapy on bone mineral density and body composition in transwomen.

Tayane Muniz FigheraEliane da SilvaJuliana Dal-Ri LindenauPoli Mara Spritzer

Published in: Clinical endocrinology (2018)

The fairly high prevalence of low bone mass in this sample of transwomen from southern Brazil seems to be related to lower ALM. Non-pharmacological lifestyle-related strategies for preventing bone loss could be beneficial for transgender women receiving long-term CSHT.

Keyphrases

bone mineral density
body composition
bone loss
postmenopausal women
resistance training
metabolic syndrome
type diabetes
cardiovascular disease
physical activity
polycystic ovary syndrome
weight loss
stem cells
hiv infected
human immunodeficiency virus
hiv testing
cell therapy
antiretroviral therapy
soft tissue